A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
Status: Recruiting
Location: See all (37) locations...
Study Type: Observational
SUMMARY
TARGET-IBD is a 5-year, longitudinal, observational study of adult and pediatric patients (age 2 and above) being managed for Inflammatory Bowel Disease (IBD) in usual clinical practice. TARGET-IBD will create a research registry of patients with IBD within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 2
Healthy Volunteers: f
View:
• Adults and children (age 2 or older) with a diagnosis of Crohn's disease (CD), Ulcerative colitis (UC), or Indeterminate colitis (IBDU) having been prescribed any IBD treatment (initial or subsequent) outside of a clinical trial.
• Have plans for future visits at the site for continued management of IBD.
Locations
United States
California
Om Research
TERMINATED
Lancaster
FACEY Medical Foundation
TERMINATED
Mission Hills
University of California - Davis
TERMINATED
Sacramento
Stanford University
TERMINATED
Stanford
Colorado
University of Colorado Denver
RECRUITING
Aurora
Florida
Gastro Florida
RECRUITING
Clearwater
University of Florida Health Jacksonville-Gastroenterology
TERMINATED
Jacksonville
Advanced Gastroenterology Associates, LLC
TERMINATED
Palm Harbor
Georgia
Atlanta Gastro
TERMINATED
Atlanta
Iowa
University of Iowa Hospitals and Clinics
RECRUITING
Iowa City
Illinois
The University of Chicago Medical Center
TERMINATED
Chicago
Indiana
Indianapolis Gastroenterology Research Foundation
TERMINATED
Indianapolis
Louisiana
Gastroenterology Associates
TERMINATED
Baton Rouge
Louisiana Research Center, LLC
TERMINATED
Shreveport
Michigan
University of Michigan Medical Center
TERMINATED
Ann Arbor
Minnesota
University of Minnesota
TERMINATED
Minneapolis
Missouri
Saint Louis University
TERMINATED
St Louis
North Carolina
Cary Gastroenterology Associates
TERMINATED
Cary
University of North Carolina
TERMINATED
Chapel Hill
Carolinas Healthcare System-Center for Digestive Health
TERMINATED
Charlotte
Digestive Health Specialists, PA
TERMINATED
Winston-salem
Nebraska
University of Nebraska Medical Center
RECRUITING
Omaha
New Hampshire
Dartmouth-Hitchcock Medical Center
TERMINATED
Lebanon
New Jersey
Rutgers, Robert Wood Johnson Medical School
TERMINATED
New Brunswick
New York
Mount Sinai, Icahn School of Medicine
RECRUITING
New York
NYU Langone Health
TERMINATED
New York
Premier Medical Group of the Hudson Valley
TERMINATED
Poughkeepsie
The Children's Hospital at Montefiore
TERMINATED
The Bronx
Ohio
Cleveland Clinic/DIgestive Disease and Surgery Institute
TERMINATED
Cleveland
The Ohio State University Wexner Medical Center
TERMINATED
Columbus
Pennsylvania
University of Pennsylvania
RECRUITING
Philadelphia
Tennessee
Vanderbilt University Medical Center
TERMINATED
Nashville
Texas
UT Southwestern
TERMINATED
Dallas
Baylor College of Medicine
TERMINATED
Houston
Washington
Swedish Medical Center
TERMINATED
Seattle
MultiCare Institute for Research and Innovation
TERMINATED
Tacoma
Wisconsin
University of Wisconsin Hospital & Clinics
RECRUITING
Madison
Contact Information
Primary
Laura Dalfonso
ldalfonso@targetpharmasolutions.com
9842340268
Time Frame
Start Date: 2017-07-24
Estimated Completion Date: 2025-10
Participants
Target number of participants: 15000
Related Therapeutic Areas
Sponsors
Leads: Target PharmaSolutions, Inc.